← Leaderboards
Gregory J Heller
University Of Illinois At Chicago
$209,456
Attributed
$209,456
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$209,456 · 1
By mechanism
F30$209,456 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Ernesto Roque Bongarzone$5,828,807
- Janean E Holden$5,034,606
- Karyn Ann Esser$18,858,503
- Tuba Fehr$176,682
- Michael Marshall$135,948
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical Trials3 Year OldAdeno-Associated Viral VectorClinically RelevantAffectAftercareAgedAnimalsArchitectureAdultBehavioralBiochemicalBirthBrainBurden Of IllnessCapsid ProteinsCatabolismCell MembraneCellsCell TypeCessation Of LifeCharacteristicsChronic Neurologic DiseaseComplementary Dna
Grant awards (4)
Improving AAV-based gene therapy for Krabbe Disease$53,974
F30 · FY2024 · HD · contact PI
Improving AAV-based gene therapy for Krabbe Disease$52,694
F30 · FY2023 · HD · contact PI
Improving AAV-based gene therapy for Krabbe Disease$51,752
F30 · FY2022 · HD · contact PI
Improving AAV-based gene therapy for Krabbe Disease$51,036
F30 · FY2021 · HD · contact PI